MGTA Annual D&A
$1.93 M
-$95.00 K-4.70%
31 December 2022
Summary:
As of January 21, 2025, MGTA annual depreciation & amortization is $1.93 million, with the most recent change of -$95.00 thousand (-4.70%) on December 31, 2022. During the last 3 years, it has risen by +$82.00 thousand (+4.45%).MGTA Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly D&A
$0.00
-$421.00 K-100.00%
30 June 2023
Summary:
As of January 21, 2025, MGTA quarterly depreciation & amortization is $0.00, with the most recent change of -$421.00 thousand (-100.00%) on June 30, 2023. Over the past year, it has dropped by -$477.00 thousand (-100.00%).MGTA Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA TTM D&A
$1.36 M
-$477.00 K-25.99%
30 June 2023
Summary:
As of January 21, 2025, MGTA TTM depreciation & amortization is $1.36 million, with the most recent change of -$477.00 thousand (-25.99%) on June 30, 2023. Over the past year, it has dropped by -$697.00 thousand (-33.92%).MGTA TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -4.7% | -100.0% | -33.9% |
| 3 y3 years | +4.5% | -100.0% | -30.6% |
| 5 y5 years | +412.0% | -100.0% | -26.3% |
MGTA Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -4.7% | -100.0% | -34.0% |
Magenta Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $0.00(-100.0%) | $1.36 M(-26.0%) |
| Mar 2023 | - | $421.00 K(-9.7%) | $1.83 M(-4.7%) |
| Dec 2022 | $1.93 M(-4.7%) | $466.00 K(-1.1%) | $1.93 M(-3.5%) |
| Sept 2022 | - | $471.00 K(-1.3%) | $1.99 M(-3.0%) |
| June 2022 | - | $477.00 K(-6.7%) | $2.06 M(-0.1%) |
| Mar 2022 | - | $511.00 K(-4.5%) | $2.06 M(+1.8%) |
| Dec 2021 | $2.02 M(+2.1%) | $535.00 K(+0.6%) | $2.02 M(+2.0%) |
| Sept 2021 | - | $532.00 K(+11.1%) | $1.98 M(+1.9%) |
| June 2021 | - | $479.00 K(+1.1%) | $1.94 M(-0.8%) |
| Mar 2021 | - | $474.00 K(-4.2%) | $1.96 M(-1.0%) |
| Dec 2020 | $1.98 M | $495.00 K(0.0%) | $1.98 M(+0.5%) |
| Sept 2020 | - | $495.00 K(0.0%) | $1.97 M(+0.6%) |
| June 2020 | - | $495.00 K(+0.4%) | $1.96 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | $493.00 K(+1.6%) | $1.91 M(+3.8%) |
| Dec 2019 | $1.84 M(+110.6%) | $485.00 K(+0.4%) | $1.84 M(+7.3%) |
| Sept 2019 | - | $483.00 K(+6.9%) | $1.72 M(+19.0%) |
| June 2019 | - | $452.00 K(+6.9%) | $1.44 M(+25.4%) |
| Mar 2019 | - | $423.00 K(+17.8%) | $1.15 M(+31.5%) |
| Dec 2018 | $875.00 K(+132.7%) | $359.00 K(+71.8%) | $875.00 K(+35.7%) |
| Sept 2018 | - | $209.00 K(+30.6%) | $645.00 K(+16.4%) |
| June 2018 | - | $160.00 K(+8.8%) | $554.00 K(+13.1%) |
| Mar 2018 | - | $147.00 K(+14.0%) | $490.00 K(+30.3%) |
| Dec 2017 | $376.00 K(+6166.7%) | $129.00 K(+9.3%) | $376.00 K(+52.2%) |
| Sept 2017 | - | $118.00 K(+22.9%) | $247.00 K(+91.5%) |
| June 2017 | - | $96.00 K(+190.9%) | $129.00 K(+290.9%) |
| Mar 2017 | - | $33.00 K | $33.00 K |
| Dec 2016 | $6000.00 | - | - |
FAQ
- What is Magenta Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Magenta Therapeutics?
- What is Magenta Therapeutics annual D&A year-on-year change?
- What is Magenta Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly D&A year-on-year change?
- What is Magenta Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Magenta Therapeutics?
- What is Magenta Therapeutics TTM D&A year-on-year change?
What is Magenta Therapeutics annual depreciation & amortization?
The current annual D&A of MGTA is $1.93 M
What is the all time high annual D&A for Magenta Therapeutics?
Magenta Therapeutics all-time high annual depreciation & amortization is $2.02 M
What is Magenta Therapeutics annual D&A year-on-year change?
Over the past year, MGTA annual depreciation & amortization has changed by -$95.00 K (-4.70%)
What is Magenta Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of MGTA is $0.00
What is the all time high quarterly D&A for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly depreciation & amortization is $535.00 K
What is Magenta Therapeutics quarterly D&A year-on-year change?
Over the past year, MGTA quarterly depreciation & amortization has changed by -$477.00 K (-100.00%)
What is Magenta Therapeutics TTM depreciation & amortization?
The current TTM D&A of MGTA is $1.36 M
What is the all time high TTM D&A for Magenta Therapeutics?
Magenta Therapeutics all-time high TTM depreciation & amortization is $2.06 M
What is Magenta Therapeutics TTM D&A year-on-year change?
Over the past year, MGTA TTM depreciation & amortization has changed by -$697.00 K (-33.92%)